Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Indians, North American | 15 | 2024 | 355 | 3.730 |
Why?
|
Tuberculosis, Multidrug-Resistant | 39 | 2016 | 931 | 3.300 |
Why?
|
Antitubercular Agents | 37 | 2016 | 1374 | 2.830 |
Why?
|
Directly Observed Therapy | 11 | 2018 | 140 | 2.460 |
Why?
|
Peru | 45 | 2023 | 870 | 2.320 |
Why?
|
Community-Institutional Relations | 7 | 2020 | 207 | 2.280 |
Why?
|
Tuberculosis | 20 | 2016 | 2003 | 1.920 |
Why?
|
Antiretroviral Therapy, Highly Active | 9 | 2019 | 1894 | 1.660 |
Why?
|
Community Health Services | 8 | 2020 | 654 | 1.380 |
Why?
|
HIV Infections | 24 | 2023 | 17159 | 1.300 |
Why?
|
Fruit | 3 | 2021 | 1162 | 1.110 |
Why?
|
Vegetables | 3 | 2021 | 1198 | 1.110 |
Why?
|
Program Evaluation | 8 | 2020 | 2494 | 1.040 |
Why?
|
Alcoholism | 7 | 2016 | 1961 | 1.020 |
Why?
|
Mycobacterium tuberculosis | 18 | 2016 | 1905 | 0.910 |
Why?
|
Naltrexone | 4 | 2013 | 317 | 0.880 |
Why?
|
Community-Based Participatory Research | 2 | 2024 | 221 | 0.870 |
Why?
|
Russia | 13 | 2016 | 381 | 0.850 |
Why?
|
Tuberculosis, Pulmonary | 14 | 2016 | 832 | 0.820 |
Why?
|
Social Support | 10 | 2022 | 2145 | 0.820 |
Why?
|
Diabetes Mellitus | 5 | 2020 | 5884 | 0.760 |
Why?
|
Food Supply | 5 | 2022 | 542 | 0.750 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 3 | 2010 | 85 | 0.710 |
Why?
|
Drug Resistance, Multiple, Bacterial | 9 | 2014 | 586 | 0.690 |
Why?
|
Nutritional Requirements | 1 | 2021 | 275 | 0.690 |
Why?
|
Poverty | 10 | 2023 | 2695 | 0.680 |
Why?
|
Health Services, Indigenous | 2 | 2018 | 68 | 0.670 |
Why?
|
New Mexico | 5 | 2020 | 83 | 0.650 |
Why?
|
Nutritive Value | 1 | 2021 | 349 | 0.620 |
Why?
|
Health Promotion | 4 | 2024 | 2208 | 0.560 |
Why?
|
Pregnancy in Diabetics | 1 | 2018 | 194 | 0.560 |
Why?
|
Patient Participation | 4 | 2020 | 1437 | 0.560 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2019 | 936 | 0.520 |
Why?
|
Arizona | 3 | 2020 | 109 | 0.500 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3159 | 0.500 |
Why?
|
Utah | 3 | 2020 | 131 | 0.500 |
Why?
|
Financial Management | 2 | 2022 | 161 | 0.500 |
Why?
|
Parenting | 1 | 2021 | 695 | 0.490 |
Why?
|
Southwestern United States | 3 | 2020 | 39 | 0.480 |
Why?
|
Antibiotics, Antitubercular | 3 | 2005 | 101 | 0.470 |
Why?
|
Professional Role | 1 | 2017 | 311 | 0.460 |
Why?
|
Urban Population | 4 | 2011 | 2021 | 0.460 |
Why?
|
United States Indian Health Service | 2 | 2024 | 31 | 0.450 |
Why?
|
Health Education | 1 | 2020 | 1049 | 0.430 |
Why?
|
Alcohol Deterrents | 1 | 2013 | 48 | 0.430 |
Why?
|
Needs Assessment | 3 | 2016 | 1137 | 0.430 |
Why?
|
Clinical Laboratory Information Systems | 5 | 2014 | 108 | 0.410 |
Why?
|
Microbial Sensitivity Tests | 12 | 2016 | 1952 | 0.390 |
Why?
|
Laboratories | 5 | 2014 | 461 | 0.390 |
Why?
|
Viral Load | 3 | 2023 | 3323 | 0.390 |
Why?
|
Residence Characteristics | 4 | 2018 | 2058 | 0.390 |
Why?
|
Medication Adherence | 4 | 2022 | 2163 | 0.390 |
Why?
|
AIDS-Related Opportunistic Infections | 4 | 2012 | 661 | 0.380 |
Why?
|
Qualitative Research | 8 | 2022 | 2958 | 0.370 |
Why?
|
Social Stigma | 2 | 2014 | 731 | 0.360 |
Why?
|
Humans | 114 | 2024 | 760261 | 0.350 |
Why?
|
Behavior Therapy | 2 | 2013 | 869 | 0.350 |
Why?
|
Anti-HIV Agents | 4 | 2023 | 4492 | 0.350 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2009 | 2127 | 0.340 |
Why?
|
Adult | 54 | 2023 | 219847 | 0.340 |
Why?
|
Social Justice | 1 | 2014 | 478 | 0.330 |
Why?
|
Child Development | 2 | 2022 | 2280 | 0.320 |
Why?
|
Female | 69 | 2024 | 391011 | 0.320 |
Why?
|
Tuberculosis, Cutaneous | 1 | 2008 | 17 | 0.320 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2008 | 16 | 0.320 |
Why?
|
Patient Compliance | 6 | 2022 | 2689 | 0.320 |
Why?
|
Male | 64 | 2024 | 359413 | 0.320 |
Why?
|
Rifampin | 2 | 2011 | 341 | 0.290 |
Why?
|
Verbal Behavior | 1 | 2008 | 335 | 0.290 |
Why?
|
Cause of Death | 1 | 2017 | 3723 | 0.280 |
Why?
|
Stereotyping | 1 | 2008 | 239 | 0.270 |
Why?
|
Health Personnel | 3 | 2020 | 3310 | 0.270 |
Why?
|
Patient Care Management | 1 | 2009 | 303 | 0.270 |
Why?
|
Counseling | 4 | 2019 | 1550 | 0.260 |
Why?
|
Treatment Outcome | 26 | 2023 | 64947 | 0.250 |
Why?
|
Middle Aged | 34 | 2024 | 220175 | 0.250 |
Why?
|
Career Choice | 1 | 2012 | 755 | 0.250 |
Why?
|
HIV | 2 | 2012 | 1579 | 0.250 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 12281 | 0.250 |
Why?
|
Health Status | 4 | 2023 | 4081 | 0.240 |
Why?
|
Psychometrics | 1 | 2014 | 3049 | 0.240 |
Why?
|
Rural Population | 4 | 2024 | 2267 | 0.240 |
Why?
|
Public Health | 2 | 2022 | 2655 | 0.230 |
Why?
|
Interviews as Topic | 6 | 2020 | 2656 | 0.230 |
Why?
|
Patient Readmission | 1 | 2018 | 3327 | 0.230 |
Why?
|
Language | 2 | 2014 | 1532 | 0.220 |
Why?
|
Cycloserine | 1 | 2004 | 118 | 0.220 |
Why?
|
Psychoses, Substance-Induced | 1 | 2004 | 99 | 0.220 |
Why?
|
Mental Health | 3 | 2022 | 3206 | 0.220 |
Why?
|
Prevalence | 8 | 2023 | 15687 | 0.220 |
Why?
|
Hypokalemia | 1 | 2004 | 153 | 0.210 |
Why?
|
HIV Seropositivity | 1 | 2008 | 955 | 0.210 |
Why?
|
Young Adult | 14 | 2023 | 58673 | 0.210 |
Why?
|
Drug Resistance, Multiple | 2 | 2003 | 254 | 0.210 |
Why?
|
Narcotic Antagonists | 3 | 2013 | 582 | 0.210 |
Why?
|
Prisoners | 1 | 2006 | 310 | 0.210 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2005 | 367 | 0.210 |
Why?
|
Nutrition Disorders | 1 | 2023 | 205 | 0.200 |
Why?
|
Attitude of Health Personnel | 2 | 2017 | 3870 | 0.200 |
Why?
|
Primary Health Care | 2 | 2022 | 4649 | 0.200 |
Why?
|
Developing Countries | 8 | 2020 | 2880 | 0.200 |
Why?
|
Drug Therapy, Combination | 9 | 2016 | 6499 | 0.200 |
Why?
|
Program Development | 4 | 2012 | 1297 | 0.200 |
Why?
|
Focus Groups | 3 | 2022 | 1372 | 0.190 |
Why?
|
Food | 2 | 2023 | 772 | 0.190 |
Why?
|
Retrospective Studies | 26 | 2023 | 80301 | 0.190 |
Why?
|
Taxes | 1 | 2023 | 222 | 0.180 |
Why?
|
Medically Underserved Area | 3 | 2012 | 258 | 0.180 |
Why?
|
Sputum | 6 | 2016 | 503 | 0.180 |
Why?
|
Telephone | 1 | 2024 | 623 | 0.180 |
Why?
|
Proportional Hazards Models | 8 | 2017 | 12532 | 0.180 |
Why?
|
Organizations, Nonprofit | 2 | 2020 | 105 | 0.180 |
Why?
|
Adolescent | 23 | 2023 | 87747 | 0.170 |
Why?
|
Commerce | 2 | 2022 | 604 | 0.170 |
Why?
|
Child, Preschool | 13 | 2024 | 42034 | 0.170 |
Why?
|
Beverages | 2 | 2023 | 819 | 0.170 |
Why?
|
Sex Distribution | 3 | 2011 | 2295 | 0.170 |
Why?
|
Brain Diseases | 1 | 2008 | 1540 | 0.170 |
Why?
|
Trust | 2 | 2017 | 528 | 0.160 |
Why?
|
Mass Screening | 3 | 2011 | 5422 | 0.160 |
Why?
|
Methicillin Resistance | 1 | 1999 | 199 | 0.160 |
Why?
|
Caregivers | 2 | 2023 | 2222 | 0.150 |
Why?
|
Physicians | 3 | 2013 | 4590 | 0.150 |
Why?
|
Combined Modality Therapy | 5 | 2016 | 8551 | 0.150 |
Why?
|
Cohort Studies | 15 | 2023 | 41317 | 0.150 |
Why?
|
Prescriptions | 1 | 2020 | 388 | 0.150 |
Why?
|
Sexual Partners | 1 | 2022 | 750 | 0.140 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2003 | 708 | 0.140 |
Why?
|
Government Regulation | 1 | 2021 | 526 | 0.140 |
Why?
|
Alcohol-Related Disorders | 2 | 2010 | 235 | 0.140 |
Why?
|
Infant | 8 | 2022 | 36030 | 0.140 |
Why?
|
Psychology | 2 | 2009 | 355 | 0.140 |
Why?
|
Pilot Projects | 3 | 2022 | 8553 | 0.130 |
Why?
|
Geography | 1 | 2018 | 661 | 0.130 |
Why?
|
Postnatal Care | 1 | 2018 | 260 | 0.130 |
Why?
|
Risk Factors | 13 | 2023 | 74269 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1679 | 0.130 |
Why?
|
United States | 12 | 2024 | 72363 | 0.130 |
Why?
|
Child | 15 | 2024 | 79758 | 0.130 |
Why?
|
Professional-Patient Relations | 2 | 2020 | 725 | 0.130 |
Why?
|
Aged | 13 | 2024 | 168995 | 0.130 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 2628 | 0.120 |
Why?
|
Case-Control Studies | 4 | 2022 | 22041 | 0.120 |
Why?
|
Time Factors | 10 | 2018 | 40133 | 0.120 |
Why?
|
Alaska | 1 | 2014 | 68 | 0.120 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1727 | 0.110 |
Why?
|
Aged, 80 and over | 5 | 2020 | 58947 | 0.110 |
Why?
|
Practice Guidelines as Topic | 5 | 2024 | 7468 | 0.110 |
Why?
|
Appointments and Schedules | 1 | 2018 | 443 | 0.110 |
Why?
|
Health Services Needs and Demand | 2 | 2012 | 1399 | 0.110 |
Why?
|
Emotions | 2 | 2019 | 2730 | 0.110 |
Why?
|
Quality Assurance, Health Care | 3 | 2008 | 2178 | 0.110 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15740 | 0.110 |
Why?
|
Attitude to Health | 2 | 2020 | 2028 | 0.110 |
Why?
|
Guideline Adherence | 3 | 2024 | 2283 | 0.110 |
Why?
|
Prospective Studies | 6 | 2020 | 54263 | 0.110 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2005 | 2494 | 0.100 |
Why?
|
Sexual Behavior | 1 | 2022 | 2080 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2852 | 0.100 |
Why?
|
Depressive Disorder | 1 | 2004 | 3728 | 0.090 |
Why?
|
Heart Failure | 3 | 2024 | 11835 | 0.090 |
Why?
|
Population Surveillance | 3 | 2011 | 2609 | 0.090 |
Why?
|
Multi-Institutional Systems | 1 | 2010 | 43 | 0.090 |
Why?
|
Patient Credit and Collection | 1 | 2010 | 16 | 0.090 |
Why?
|
Prenatal Care | 1 | 2018 | 1128 | 0.090 |
Why?
|
Logistic Models | 3 | 2018 | 13311 | 0.090 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25928 | 0.090 |
Why?
|
Anthropology, Cultural | 1 | 2010 | 101 | 0.090 |
Why?
|
Pregnancy | 5 | 2023 | 29725 | 0.090 |
Why?
|
Poverty Areas | 1 | 2011 | 264 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6545 | 0.090 |
Why?
|
Empathy | 1 | 2014 | 473 | 0.090 |
Why?
|
Tetrazolium Salts | 1 | 2009 | 92 | 0.080 |
Why?
|
Narration | 1 | 2012 | 218 | 0.080 |
Why?
|
Mycobacterium avium Complex | 1 | 2009 | 59 | 0.080 |
Why?
|
Culture Media | 2 | 2009 | 899 | 0.080 |
Why?
|
Isoniazid | 1 | 2011 | 283 | 0.080 |
Why?
|
Anxiety | 1 | 2004 | 4532 | 0.080 |
Why?
|
Clarithromycin | 1 | 2009 | 85 | 0.080 |
Why?
|
Pneumonectomy | 1 | 2016 | 1110 | 0.080 |
Why?
|
Mental Health Services | 1 | 2020 | 1716 | 0.080 |
Why?
|
Depression | 1 | 2008 | 8033 | 0.080 |
Why?
|
Mothers | 1 | 2019 | 2186 | 0.080 |
Why?
|
Immune Reconstitution Inflammatory Syndrome | 1 | 2008 | 61 | 0.080 |
Why?
|
Confidence Intervals | 2 | 2012 | 2932 | 0.080 |
Why?
|
Delivery of Health Care | 3 | 2012 | 5324 | 0.080 |
Why?
|
Public Health Administration | 2 | 2007 | 243 | 0.070 |
Why?
|
Age Distribution | 2 | 2004 | 2893 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2014 | 3967 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12156 | 0.070 |
Why?
|
Survival Analysis | 2 | 2017 | 10185 | 0.070 |
Why?
|
Microbiological Techniques | 1 | 2008 | 98 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3005 | 0.070 |
Why?
|
Siphonaptera | 1 | 2006 | 6 | 0.070 |
Why?
|
Ectoparasitic Infestations | 1 | 2006 | 11 | 0.070 |
Why?
|
Education, Medical, Continuing | 1 | 2012 | 830 | 0.070 |
Why?
|
Cost of Illness | 2 | 2023 | 1940 | 0.070 |
Why?
|
Peer Group | 1 | 2011 | 674 | 0.070 |
Why?
|
Treatment Failure | 3 | 2016 | 2646 | 0.070 |
Why?
|
Efficiency, Organizational | 1 | 2010 | 697 | 0.070 |
Why?
|
Infant, Newborn | 4 | 2018 | 26168 | 0.070 |
Why?
|
Urban Health | 1 | 2008 | 533 | 0.070 |
Why?
|
Superinfection | 1 | 2006 | 64 | 0.060 |
Why?
|
Medical Errors | 1 | 2014 | 1255 | 0.060 |
Why?
|
Information Systems | 1 | 2007 | 398 | 0.060 |
Why?
|
Health Plan Implementation | 2 | 2007 | 335 | 0.060 |
Why?
|
Health Policy | 2 | 2022 | 2678 | 0.060 |
Why?
|
Professional Competence | 1 | 2008 | 431 | 0.060 |
Why?
|
Substance-Related Disorders | 2 | 2020 | 4370 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6771 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3475 | 0.060 |
Why?
|
Drug Administration Schedule | 4 | 2016 | 4900 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14482 | 0.060 |
Why?
|
Comorbidity | 3 | 2023 | 10552 | 0.060 |
Why?
|
Treatment Refusal | 1 | 2008 | 430 | 0.060 |
Why?
|
Patients | 1 | 2011 | 906 | 0.060 |
Why?
|
Databases, Factual | 2 | 2017 | 8018 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6472 | 0.060 |
Why?
|
Capreomycin | 1 | 2004 | 14 | 0.060 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2007 | 488 | 0.060 |
Why?
|
Drug Resistance, Microbial | 2 | 2005 | 858 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 1 | 2010 | 2569 | 0.060 |
Why?
|
Clinical Protocols | 3 | 2014 | 1439 | 0.060 |
Why?
|
Blood Glucose | 1 | 2018 | 6375 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 1988 | 0.060 |
Why?
|
Sex Factors | 1 | 2017 | 10530 | 0.060 |
Why?
|
Metabolism, Inborn Errors | 1 | 2005 | 285 | 0.050 |
Why?
|
Contact Tracing | 1 | 2005 | 268 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2010 | 6017 | 0.050 |
Why?
|
Primary Prevention | 1 | 2010 | 1207 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4763 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2016 | 39254 | 0.050 |
Why?
|
Ambulatory Care | 3 | 2008 | 2783 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2013 | 5201 | 0.050 |
Why?
|
Self Care | 1 | 2007 | 793 | 0.050 |
Why?
|
Information Dissemination | 1 | 2010 | 1132 | 0.050 |
Why?
|
Lesotho | 1 | 2022 | 74 | 0.050 |
Why?
|
Inservice Training | 1 | 2004 | 376 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2009 | 1784 | 0.050 |
Why?
|
Incidence | 4 | 2023 | 21378 | 0.050 |
Why?
|
Regression Analysis | 1 | 2011 | 6361 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2010 | 1208 | 0.050 |
Why?
|
Preventive Health Services | 1 | 2006 | 571 | 0.050 |
Why?
|
Insurance Benefits | 1 | 2023 | 191 | 0.050 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2007 | 1349 | 0.050 |
Why?
|
Odds Ratio | 2 | 2012 | 9712 | 0.050 |
Why?
|
Respiratory Insufficiency | 1 | 2010 | 1228 | 0.050 |
Why?
|
Risk Assessment | 3 | 2017 | 24086 | 0.050 |
Why?
|
Atrial Flutter | 1 | 2023 | 258 | 0.050 |
Why?
|
Mutation | 2 | 2005 | 29950 | 0.050 |
Why?
|
Pelvic Bones | 1 | 2003 | 271 | 0.050 |
Why?
|
HIV-1 | 2 | 2009 | 6850 | 0.050 |
Why?
|
Interview, Psychological | 1 | 2004 | 812 | 0.050 |
Why?
|
Antibodies, Viral | 1 | 2012 | 3145 | 0.050 |
Why?
|
Age Factors | 1 | 2017 | 18415 | 0.050 |
Why?
|
Neonatal Screening | 1 | 2005 | 595 | 0.040 |
Why?
|
Magnesium | 1 | 2004 | 810 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2011 | 7803 | 0.040 |
Why?
|
Family Characteristics | 1 | 2005 | 1001 | 0.040 |
Why?
|
Communication | 1 | 2014 | 3846 | 0.040 |
Why?
|
Cross Infection | 1 | 2008 | 1434 | 0.040 |
Why?
|
Food Preferences | 1 | 2022 | 399 | 0.040 |
Why?
|
Radiography | 1 | 2010 | 6965 | 0.040 |
Why?
|
Cooperative Behavior | 2 | 2020 | 1500 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2014 | 4361 | 0.040 |
Why?
|
Medical Records | 1 | 2004 | 1407 | 0.040 |
Why?
|
Nutrition Policy | 1 | 2022 | 470 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2012 | 5420 | 0.040 |
Why?
|
Survival Rate | 1 | 2012 | 12806 | 0.040 |
Why?
|
Drug Resistance, Bacterial | 1 | 2005 | 1054 | 0.040 |
Why?
|
Self Efficacy | 1 | 2022 | 629 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2008 | 15827 | 0.040 |
Why?
|
Capacity Building | 1 | 2020 | 258 | 0.040 |
Why?
|
Electromyography | 1 | 2003 | 1386 | 0.040 |
Why?
|
Secondary Prevention | 2 | 2016 | 1548 | 0.040 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 899 | 0.040 |
Why?
|
Hospitalization | 1 | 2017 | 10761 | 0.040 |
Why?
|
Decision Making | 1 | 2011 | 3924 | 0.040 |
Why?
|
Developed Countries | 1 | 2020 | 443 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4276 | 0.040 |
Why?
|
Health Planning | 1 | 1998 | 232 | 0.040 |
Why?
|
Water | 1 | 2023 | 1402 | 0.040 |
Why?
|
India | 1 | 2024 | 2346 | 0.040 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 495 | 0.030 |
Why?
|
Korea | 2 | 2005 | 96 | 0.030 |
Why?
|
Morals | 1 | 1998 | 289 | 0.030 |
Why?
|
Quality Control | 2 | 2008 | 827 | 0.030 |
Why?
|
Unsafe Sex | 1 | 2016 | 213 | 0.030 |
Why?
|
National Health Programs | 2 | 2010 | 442 | 0.030 |
Why?
|
Risk | 2 | 2016 | 9629 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4717 | 0.030 |
Why?
|
Learning | 1 | 2022 | 1733 | 0.030 |
Why?
|
World Health Organization | 1 | 1998 | 1319 | 0.030 |
Why?
|
Diglycerides | 1 | 1993 | 176 | 0.030 |
Why?
|
Georgia (Republic) | 1 | 2011 | 39 | 0.030 |
Why?
|
Recurrence | 2 | 2016 | 8487 | 0.020 |
Why?
|
Tuberculin Test | 1 | 2012 | 206 | 0.020 |
Why?
|
Ceramides | 1 | 1993 | 200 | 0.020 |
Why?
|
Lung | 1 | 2010 | 9989 | 0.020 |
Why?
|
Protein-Energy Malnutrition | 1 | 2012 | 188 | 0.020 |
Why?
|
Endemic Diseases | 1 | 2012 | 191 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2012 | 574 | 0.020 |
Why?
|
Complement Activation | 1 | 1993 | 446 | 0.020 |
Why?
|
Drug Therapy | 1 | 2014 | 504 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10829 | 0.020 |
Why?
|
Retreatment | 1 | 2012 | 600 | 0.020 |
Why?
|
Siberia | 1 | 2009 | 30 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5513 | 0.020 |
Why?
|
Risk-Taking | 1 | 2016 | 1000 | 0.020 |
Why?
|
Geographic Information Systems | 1 | 2012 | 280 | 0.020 |
Why?
|
Disease Outbreaks | 2 | 2012 | 1759 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 422 | 0.020 |
Why?
|
Hospitals, Chronic Disease | 1 | 2008 | 8 | 0.020 |
Why?
|
Disease Management | 1 | 1999 | 2508 | 0.020 |
Why?
|
Bacteriology | 1 | 2007 | 10 | 0.020 |
Why?
|
HIV Seronegativity | 1 | 2008 | 208 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2008 | 20484 | 0.020 |
Why?
|
Demography | 1 | 2012 | 1650 | 0.020 |
Why?
|
Internet | 2 | 2010 | 3074 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 1999 | 5507 | 0.020 |
Why?
|
Education | 1 | 2008 | 535 | 0.020 |
Why?
|
Rural Health | 1 | 2006 | 299 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6242 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3568 | 0.010 |
Why?
|
Haiti | 1 | 2006 | 550 | 0.010 |
Why?
|
Blood Specimen Collection | 1 | 2005 | 238 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6661 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8621 | 0.010 |
Why?
|
Leg Length Inequality | 1 | 2003 | 56 | 0.010 |
Why?
|
Sacroiliac Joint | 1 | 2003 | 57 | 0.010 |
Why?
|
Acidosis | 1 | 2005 | 271 | 0.010 |
Why?
|
Interdisciplinary Communication | 1 | 2008 | 934 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2009 | 2434 | 0.010 |
Why?
|
Diet | 1 | 2020 | 8008 | 0.010 |
Why?
|
Drug Tolerance | 1 | 2003 | 369 | 0.010 |
Why?
|
Community Health Centers | 1 | 2005 | 453 | 0.010 |
Why?
|
Prognosis | 2 | 2012 | 29636 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2007 | 926 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36247 | 0.010 |
Why?
|
Stroke | 1 | 2023 | 9945 | 0.010 |
Why?
|
Animals | 3 | 2009 | 167940 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 2003 | 532 | 0.010 |
Why?
|
Algorithms | 2 | 2012 | 13967 | 0.010 |
Why?
|
Life Style | 1 | 2011 | 3888 | 0.010 |
Why?
|
China | 1 | 2005 | 2340 | 0.010 |
Why?
|
Amino Acids | 1 | 2005 | 1715 | 0.010 |
Why?
|
Quality Improvement | 1 | 2014 | 3840 | 0.010 |
Why?
|
Sampling Studies | 1 | 2000 | 614 | 0.010 |
Why?
|
Research Design | 1 | 2014 | 6181 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2005 | 2192 | 0.010 |
Why?
|
Fatty Acids | 1 | 2005 | 1805 | 0.010 |
Why?
|
Anti-Retroviral Agents | 1 | 2006 | 1780 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2009 | 3242 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2008 | 3598 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14656 | 0.010 |
Why?
|
Complement C9 | 1 | 1993 | 15 | 0.010 |
Why?
|
Virulence Factors, Bordetella | 1 | 1993 | 154 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 1993 | 176 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2005 | 3822 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1993 | 871 | 0.010 |
Why?
|
Phosphatidylcholines | 1 | 1993 | 406 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 12959 | 0.010 |
Why?
|
Molecular Weight | 1 | 1993 | 2186 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1993 | 1792 | 0.000 |
Why?
|
Mental Disorders | 1 | 2008 | 6797 | 0.000 |
Why?
|
Protein Kinase C | 1 | 1993 | 1201 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2006 | 15680 | 0.000 |
Why?
|
Phosphorylation | 1 | 1993 | 8314 | 0.000 |
Why?
|
Mice | 1 | 1993 | 81216 | 0.000 |
Why?
|